Ozurdex 0.7 MG implants
Ended Awarded
- Contract number
- SPE2DX25F6XTX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,022
Award facts
- Contract value 100% obligated
- $4,021.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,021.52 for OZURDEX 0.7 mg implants on September 19, 2025. The delivery order, which is not subject to any set-aside designation, is expected to be completed by October 10, 2025, and will be performed at the vendor's Park Ridge location. This award is issued under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide.
OZURDEX implants are ophthalmic corticosteroid delivery devices used to treat macular edema and other ocular inflammatory conditions. This delivery order represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, leveraging its extensive portfolio of branded and generic pharmaceutical products, biologics, and medical consumables. The company's consistent success in securing delivery orders through the SPE2DB program reflects its capability to reliably distribute specialized pharmaceutical products to military health facilities across the nation.
Quick answers
Who was awarded contract SPE2DX25F6XTX?
SPE2DX25F6XTX was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 19, 2025.
How much is contract SPE2DX25F6XTX worth?
The government has obligated $4,022 on SPE2DX25F6XTX.
Is contract SPE2DX25F6XTX an order under another contract?
Yes. SPE2DX25F6XTX is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XTX competed?
The extent of competition for SPE2DX25F6XTX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award